Transient receptor potential channels as emerging therapeutic targets: mechanisms and therapeutic insights in inflammatory bowel disease
Biochemical Pharmacology · 2026-03 · 245 · 117693
DOI: 10.1016/j.bcp.2026.117693 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2026-03. Verfasst von Ying Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nantong University, Nantong, Jiangsu 226019, PR China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Transient Receptor Potential Channels. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 222 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Graduate Research and Innovation Projects of Jiangsu Province.
Abstract (Originalsprache)
Transient Receptor Potential channels (TRPs) are a family of non-selective cation channels widely distributed across diverse tissues and cells in mammals. They participate in numerous physiological processes, including environmental stimulus perception, signal transduction, neurotransmitter release, and insulin secretion. The involvement of TRPs in pain syndromes, neurodegenerative diseases, metabolic disorders, and tumorigenesis has established them as prominent targets in translational medicine. Inflammatory Bowel Disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a chronic and relapsing inflammatory disorder of the intestine. Its pathogenesis involves complex interactions among genetic susceptibility, gut microbiota dysbiosis, immune system dysregulation, and neuroimmunomodulatory disturbances. Although the precise etiology of IBD remains incompletely elucidated, substantial evidence indicates that TRPs sense and respond to diverse intestinal luminal stimuli (e.g., bacteria, viruses, and food antigens). They participate in IBD pathophysiology by modulating inflammatory signaling, immune responses, and visceral nociception, thereby contributing to neurogenic inflammation, disruption of the intestinal barrier function, immune and metabolic dysregulation, visceral hypersensitivity, and intestinal fibrosis. Given the pivotal role of TRPs in IBD progression, this review comprehensively elaborates on the structure and function of TRPs associated with IBD, their mechanisms in disease pathology, and recent advances in TRP-targeted therapy for IBD. This article aims to provide insights into the development of innovative treatment strategies for IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nantong University, Nantong, Jiangsu 226019, PR China.
- School of Pharmacy, Nantong University, Nantong, Jiangsu 226019, PR China. Electronic address: luolin@ntu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Jiang, Y., Wang, X., Zhou, Y., Feng, Y., Gu, H., Liu, X., & Luo, L. (2026). Transient receptor potential channels as emerging therapeutic targets: mechanisms and therapeutic insights in inflammatory bowel disease. Biochemical Pharmacology, 245, 117693. https://doi.org/10.1016/j.bcp.2026.117693
Vancouver
Jiang Y, Wang X, Zhou Y, Feng Y, Gu H, Liu X, et al. Transient receptor potential channels as emerging therapeutic targets: mechanisms and therapeutic insights in inflammatory bowel disease. Biochemical Pharmacology. 2026;245:117693. doi:10.1016/j.bcp.2026.117693
BibTeX
@article{Jiang2026,
author = {Jiang, Ying and Wang, Xi and Zhou, Yinwei and Feng, Yuting and Gu, Han and Liu, Xingjun and Luo, Lin},
title = {Transient receptor potential channels as emerging therapeutic targets: mechanisms and therapeutic insights in inflammatory bowel disease},
journal = {Biochemical Pharmacology},
year = {2026},
volume = {245},
pages = {117693},
doi = {10.1016/j.bcp.2026.117693}
}
EUVIMED